EXAM 2 - Drugs Flashcards

1
Q

PD-L1 Inhibitors (lung cancer)
immune checkpoint inhibitors

A

Pembrolizumab
Atezolizumab
Cemiplimab
Nivolumab + ipilimumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

EGFR exon 19 deletion or 1858R mutation (lung cancer)

A

Osimertinib
Erlotinib
Afatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ALK rearrangements (lung cancer)

A

Alectinib
Brigatinib
Loraltinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ROS1 rearrangements (lung cancer)

A

Crizotinib
Enterctinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BRAF V600E mutation (lung cancer)

A

Trametinib
Dabrafenib
Capmatinib
Tepotinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

RET rearrangement (lung cancer)

A

Selpercatinib
Pralsetinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NTKR gene fusion positive

A

Larotrectinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

KRAS G12C mutation

A

Sotorasib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

VEGF inhibitor

A

Bevacizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antimicrotubule inhibitor

A

Cabazitaxel
Docetaxel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PARP inhibitor

A

Olaparib
Rucaparib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

androgen synthesis inhibitors

A

abiraterone acetate
ketoconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LHRH agonists

A

Goserelin
Leuprolide
Triptorelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LHRH/GnRH antagonists

A

Degarelix
Relugolix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

1st generation antiandrogens

A

Bicalutamide
Flutamide
Nilutamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd generation antiandrogens

A

Apalutamide
Darolutamide
Enzalutamide

17
Q

HER2 inhibitors

A

Trastuzumab
Pertuzumab
Iapatinib

18
Q

EGFR inhibitors

A